Sitemap > Breaking Research > Diagnostics & Devices
Displaying 651 - 700 of 1058 results
- [(11)C]AZ10419369: A selective 5-HT(1B) receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
- Meta-analysis of Four Randomized Controlled Trials on Long-Term Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Stenting for Multivessel Coronary Artery Disease.
- Meta-analysis of the Effects of Paclitaxel-Eluting Stents Versus Bare Metal Stents on Volumetric Intravascular Ultrasound in Patients With Versus Without Diabetes Mellitus.
- Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
- Monitoring Circulating Tumor Cells in Cancer Vaccine Trials.
- MBC94, a Conjugable Ligand for Cannabinoid CB2 Receptor Imaging.
- Novel tumor-ablation device for liver tumors utilizing heat energy generated under an alternating magnetic field.
- MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
- P846, a new gadolinium based low diffusion magnetic resonance contrast agent, in characterizing occlusive infarcts, reperfused ischemic myocardium and reperfused infarcts in rats.
- A meta-analysis of 21,178 patients undergoing open or endovascular repair of abdominal aortic aneurysm.
- MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
- Targeting Cell Death In Vivo in Experimental Traumatic Brain Injury by a Novel Molecular Probe.
- Rapid Detection of Chlamydia trachomatis and Typing of the Lymphogranuloma venereum associated L-Serovars by TaqMan PCR.
- An aberrant protein complex in CSF as a biomarker of Alzheimer disease.
- REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis.
- Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas.
- PGK1 a Potential Marker for Peritoneal Dissemination in Gastric Cancer.
- Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients.
- Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression.
- Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia.
- Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
- Autoantibodies as potential biomarkers for breast cancer.
- Drug-Eluting Stent Implantation for Acute Myocardial Infarction during Pregnancy with Use of Glycoprotein IIb/IIIa Inhibitor, Aspirin and Clopidogrel.
- Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison.
- Combination of functionalized nanoparticles and polymerase chain reaction-based method for SARS-CoV gene detection.
- Fabrication and application of single nucleotide polymorphisms library on magnetic nanoparticles using adaptor PCR.
- A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.
- Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer.
- Fecal Calprotectin Level Measurements in Small Bowel Allograft Monitoring: A Pilot Study.
- SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue.
- Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
- Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia.
- PDGF-BB is a Novel Prognostic Factor in Colorectal Cancer.
- Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples.
- Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I-III Colorectal Cancer after Curative Resection.
- Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer.
- A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions.
- Comparison of Effectiveness and Safety of Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With Diabetes Mellitus (from the Italian Multicenter Randomized DESSERT Study).
- Somatostatin receptor scintigraphy in advanced renal cell carcinoma. Results of a phase II-trial of somatostatine analogue therapy in patients with advanced RCC.
- Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
- Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients.
- Development of a multiplex PCR/LDR assay for detection of West Nile Virus.
- Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension.
- Is CD133 a marker of metastatic colon cancer stem cells?
- alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
- Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
- Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).
- A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells.
- Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.